,outcome,arm 1,arm 2
0,intervention,"CHF, D-99 patients",CHF
0,Protocol-defined cardiotoxicity,"13 % of TLC, 2 cases",9 cases
0,"Protocol-defined cardiotoxicity, total study group","29 % of doxorubicin, CHF","29 % of doxorubicin, CHF"
